The Canadian Pharmaceutical Manufacturers and Exporters Alliance (CPMEA) stands as a leading advocate for the growth and competitiveness of the Canadian pharmaceutical industry, striving to ensure a sustainable and prosperous future for the sector. Representing the largest manufacturers of medicines by volume in Canada, CPMEA's members produce innovative, generic, and biosimilar pharmaceuticals, along with non-prescription medications. The products made by the CPMEA members fill over 203 million prescriptions in Canada annually, representing 26% of all prescriptions dispensed in the country.
This underscores the critical role of the CPMEA in bolstering Canada's economy and public health resilience, highlighting the need to amplify the sector's voice to enhance Canada's position in the global pharmaceutical market.
Advocating for streamlined regulations and processes, the CPMEA seeks to enhance the industry's efficiency and global market access, ultimately driving growth and innovation within the Canadian pharmaceutical landscape.
Our unwavering commitment to excellence in pharmaceutical manufacturing and export compels us to persist in advocating for policies and agreements that not only foster the growth and innovation of the Canadian pharmaceutical industry but also safeguard Canada's sovereignty in pharmaceutical production.
Join us as we navigate the path toward a resilient, innovative, and prosperous future for the Canadian pharmaceutical landscape.
The Canadian Pharmaceutical Manufacturers and Exporters Alliance (CPMEA) – Alliance fabricants et exportateurs pharmaceutiques du Canada (AFEPC) represents pharmaceutical companies that manufacture in Canada. We have come together in an Alliance to tell the story of drug production in Canada and to raise awareness of the unique issues facing our industry.
Click here to contact us, or email us directly at info@cpmea.ca.